Search Results
Slidesets
Treatment Strategies from a Public Health Perspective - Meg Doherty, MD, MPH, PhD
Presented at:
INTEREST 2019
Abstracts
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal
R. Toyé
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
Long COVID - Post Exertionele Malaise (PEM).pdf
Presented at:
Nederlandse Long COVID Dag 2024
Abstracts
How many adolescents do we actually lose along the HIV treatment cascade?: Accounting for aging up in adolescent continuity of treatment
T. Simiyu.
Reviews in Antiviral Therapy & Infectious Diseases 9, 2021
Presented at:
International Workshop on HIV & Adolescence 2021
Slidesets
Early Diagnosis and Same-Day ART - Laura Waters, MD, FRCP
Presented at:
GCC HIV Clinical Forum 2022
Slidesets
Reaching Adolescent Girls and Young Women- What Interventions Work - Linda Gail Bekker.pdf
Presented at:
INTEREST 2023
Abstracts
Evaluation of the virological efficacy of switching to dolutegravir-based tritherapy in patients followed under real-life conditions in Abidjan, Côte d'Ivoire
J. Dechi
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Slidesets
Hepatitis B/C and NASH: Crossroads Between Science and Business (not available)- Geoffrey Meacham
Presented at:
HEP DART 2017
Slidesets
What is the cure rate with current therapies? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2018